Pharma Fridays — February 7, 2025
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Genentech, a member of the Roche Group on February 4 announced that the U.S. Food and Drug Administration (FDA) approved Susvimo® (ranibizumab injection) …